Inventor · disambiguated record
Ilgen Mender
Also filed as: MENDER ILGEN
2 granted patents·3 pending applications·0 citations·filing 2017–2024
29Inventor score
Files withUNIV TEXAS5
Top patents by PatentIndex Score
5 records- 0173US2024366650A1Treatment of drug resistant proliferative diseases with telomerase mediated telomere altering compoundsUNIV TEXAS·Filed 2024·Application pending·0 cites
- 0269US2024424013A1SEQUENTIAL TREATMENT OF CANCERS USING 6-THIO-dG, CHECKPOINT INHIBITORS AND RADIATION THERAPYUNIV TEXAS·Filed 2024·Application pending·0 cites
- 0366US12070472B2Treatment of drug resistant proliferative diseases with telomerase mediated telomere altering compoundsUNIV TEXAS·Filed 2019·Granted Aug 27, 2024·0 cites·8 claims
- 0461US12097213B2Sequential treatment of cancers using 6-thio-dG, checkpoint inhibitors and radiation therapyUNIV TEXAS·Filed 2021·Granted Sep 24, 2024·0 cites·16 claims
- 0543US2018036331A1Treatment of drug resistant proliferative diseases with telomerase mediated telomere altering compoundsUNIV TEXAS·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ilgen Mender files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →